Tech & Pharma

Takeda Invests In Vaccine Safe Takeda Invests In Vaccine Safe
  • October 14th, 2014
  • Alfresa’s Vaccine Scheduling System helps parents keep track of their children’s increasingly complex vaccination schedules.

» Read More...

Tech & Pharma

Takeda Invests In Vaccine Safe

Takeda Invests In Vaccine Safe

Alfresa’s Vaccine Scheduling System helps parents keep track of their children’s increasingly complex vaccination schedules.

2-In-1 Motors Boost Electric Vehicle Range

2-In-1 Motors Boost Electric Vehicle Range

By combining the traditional motor with the air-conditioning compressor, researchers have increased the range of electric vehicles by 15 to 20 percent.

Takeda Partners With American Therapeutic Accelerator BioMotiv

Takeda Partners With American Therapeutic Accelerator BioMotiv

BioMotiv and Takeda pharmaceutical company enter into a strategic partnership to identify and develop pioneering medical innovations.

Baiyunshan Gets CFDA Approval For Generic Viagra

Baiyunshan Gets CFDA Approval For Generic Viagra

The approval of Baiyunshan’s generic Viagra could help it attain market dominance in China’s erectile dysfunction sector.

Mead Johnson Opens US$325 Million Facility In Singapore

Mead Johnson Opens US$325 Million Facility In Singapore

Seeking to stay close to the growing Asian pediatric nutrition market, Mead Johnson opens a new manufacturing and research facility in Singapore.

Keeping Li-S In Its Place

Keeping Li-S In Its Place

Researchers have developed a method of containing Li-S, paving the way for more compact rechargeable batteries.

First Drug For Dementia With Lewy Bodies Approved

First Drug For Dementia With Lewy Bodies Approved

Eisai’s Aricept® is the world’s first treatment indicated for both Alzheimer’s and dementia with Lewy bodies.

Floating Solar Farms For India and Japan

Floating Solar Farms For India and Japan

Companies in Japan and India have started utilizing floating power farms to circumvent the lack of space on land.

ASLAN Commences Taiwan Trials For Gastric Cancer Drug

ASLAN Commences Taiwan Trials For Gastric Cancer Drug

ASLAN has begun treating its first gastric cancer patients in Taiwan, where 4,000 people are affected by the disease annually.

ToolGen & KAIST To Collaborate On Biofuel Gene Editing

ToolGen & KAIST To Collaborate On Biofuel Gene Editing

KAIST partners gene editing company ToolGen to develop methods of increasing biofuel yield from microalgae.